|
HAE Haemonetics Corp 313143 |
| Balance Sheet |
|
Current Assets
|
$834,879,000.00 |
|
Assets
|
$2,395,925,000.00 |
|
Current Liabilities
|
$282,599,000.00 |
|
Equity
|
$796,320,000.00 |
|
Shares Out
|
45252667.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$293,221,000.00 |
|
Investing Cash Flow
|
$-179,547,000.00 |
| Market Analysis |
Market Cap
|
$3,838,331,214.94 |
|
Price
|
$88.00 |
|
BVPS
|
17.60 |
|
PB
|
4.82 |
|
EPS
|
2.06 |
|
PE
|
37.61 |
|
PS
|
2.54 |
|
FCF
|
$260,441,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:20 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:15 |
|
| Jan |
Feb |
Mar |
|
|
|
|
2026-02-05 |
1.31 |
|
| Apr |
May |
Jun |
|
|
|
|
2026-05-07 |
1.29 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-07 |
0.70 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-06 |
1.27 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view HAE documents filed with the SEC.
HAE Filings
Clear
